SCRS is a global trade organization that represents more than 9,000 sites in 47 countries.
As a Global Impact Partner, the contract research organization (CRO) will contribute to the development and implementation of best clinical trial site practices, according to SCRS.
"Strengthening the relationship and communication between sites and other industry stakeholders is critically needed. CPi Global CRO joining SCRS' GIP program adds breadth to this initiative," said SCRS president Christine Pierre in a press release.
"We look forward to working with SCRS as a GIP to foster access and innovation in clinical trials," added Lee King, CPi Global CRO SVP and global head of global business development and strategy.
"This is another way for us to ensure drugs and treatments which can truly make a difference are given the best chance to do so," he added.